Testicular function in hypercholesterolemic male patients during prolonged simvastatin treatment

Hormone and Metabolic Research

Volumn 28, Issue 4, 1996, Pages 193-198

  Azzarito, Clorinda ^a   Boiardi, L ^a   Vergoni, W ^a   Zini, M ^a   Portioli, I ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

free testosterone; hypercholesterolemia; simvastatin; testicular function

Indexed keywords

ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; FOLLITROPIN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; SIMVASTATIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; TESTIS FUNCTION;

EID: 0029951605     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979159     Document Type: Article

References (27)

1. Andreis, P. G., L. Cavallini, G. Mazzocchi, G. G. Nussdorfer: Effects of prolonged administration of lovastatin, an inhibitor of cholesterol synthesis, on the morphology and function of rat Leydig cells. Exp. Clin. Endocrinol. 96: 15-24 (1990)
2. Azzarito, C., L. Boiardi, M. Zini, A. Agosti, C. Dotti, R. Biagi, I. Portioli: Long-term therapy with high-dose simvastatin does not affect adrenocortical and gonadal hormones in hypercholesterolemic patients. Metabolism 41: 148-153 (1992)
3. Balestrieri, G. P., S. Spandrio, A. Salvi, M. Rossi, O. DiStefano, R. Candrina: A 6-month treatment with simvastatin does not modify adrenal and testicular steroid hormones in heterozygous familial hypercholesterolemia. In: Treatment of severe hypercholesterolemia in the prevention of coronary heart disease. Pro 2nd Int. Symp. Munich 1989; Gotto, A. M. Jr., M. Mancini, W. O. Richter, P. Schwandt (eds.), Basel, Karger (1990), Vol. 2, pp. 98-103
4. Bernini, G. P., G. F. Argenio, M. Gasperi, M. S. Vivaldi, F. Franchi, A. Salvetti: Effects of long-term simvastatin treatment on testicular and adrenal steroidogenesis in hypercholesterolemic patients. J. Endocrinol. Invest. 17: 227-233 (1994)
5. Borkowski, A., C. Delcroix, S. Levin: Metabolism of adrenal cholesterol in man. I. In vivo studies. J. Clin. Invest. 51: 1664-1678 (1972)
6. Brown, M. S., P. T. Kovanen, J. L. Goldstein: Receptor mediated uptake of lipoprotein cholesterol and its utilization for steroid synthesis in the adrenal cortex. Recent. Prog. Horm. Res. 35: 215-257 (1979)
7. Carr, B. R., C. R. Parker, M. Ohashi, P. C. MacDonald, E. R. Simpson: Regulation of human fetal testicular secretion of testosterone: Low-density lipoprotein-cholesterol and cholesterol synthesized de novo as steroid precursor. Am. J. Obstet. Gynecol. 146: 241-247 (1983)
8. Cicero, T. J.: Alcohol-induced deficits in the hypothalamic-pituitary-luteinizing hormone axis in the male. Alcoholism (NY) 6: 207-215 (1982)
9. Farnsworth, W. H., J. M. Hoeg, M. Maher, E. H. Brittain, R. J. Sherins, H. B. Brewer: Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (Mevinolin) or neomycin. J. Clin. Endocrinol. Metab. 65: 546-550 (1987)
10. Gerson, R. J., J. S. MacDonald, A. W. Alberts, D. J. Kornbrust, J. A. Maijka, R. J. Stubbs, D. L. Bokelman: Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl coenzyme A reductase inhibitors. Am. J. Med. 87: (suppl. 4A): 28S-38S (1989)
11. Griffin, J. E., J. D. Wilson: Disorders of the testes and the male reproductive tract. In: Williams Textbook of Endocrinology (8th Ed.); Wilson, J. D. and Foster, D. W. (eds.), Philadelphia, PA, Saunders (1992), pp. 799-852
12. Hubbard, S., R. Ivatt: Synthesis and processing of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 50: 555-559 (1981)
13. Jay, R. H., R. H. Sturley, C. Stirling, H. H. G. McGarrigle, M. Katz, J. P. D. Reckless, D. J. Betteridge: Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia. Br. J. Clin. Pharmacol. 32: 417-422 (1991)
14. Koga, T., K. Fukuda, Y. Shimada, M. Fukami, H. Koike, Y. Tsujita: Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of the novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat. Eur. J. Biochem. 209: 315-319 (1992)
15. Kolodny, R. C., W. H. Masters, R. M. Kolodner: Depression of plasma testosterone levels after chronic intensive marihuana use. N. Engl. J. Med. 290: 872-874 (1974)
16. Mastroberardino, G., C. Costa, M. S. Gavelli, E. Vitaliano, F. Rossi, A. Catalano, R. Barletta, G. Guarini: Plasma cortisol and testosterone in hypercholesterolaemia treated with clofibrate and lovastatin. J. Int. Med. Res. 17: 388-394 (1989)
17. Mendelson, J. H., J. E. Mendelson, V. S. Patch: Plasma testosterone levels in heroin addiction and during methadone maintenance. J. Pharmacol. Exp. Ther. 192: 211-217 (1975)
18. Mol, M. J. T. M., A. F. H. Stalenhoef, P. M. J. Stuyt, A. R. M. M. Hermus, P. N. M. Demacker, A. Van'T Laar: Effects of inhibition of cholesterol synthesis by simvastatin on the production of adrenocortical steroid hormones and ACTH. Clin. Endocrinol. 31: 679-689 (1989)
19. Prihoda, J. S., A. S. Pappu, F. E. Smith, D. R. Illingworth: The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia. J. Clin. Endocrinol. Metab. 72: 567-574 (1991)
20. Purvis, K., A. Tollefsrud, H. Rui, E. Haug, J. Norseth, L. Viksmoen, L. Ose, H. Lund: Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolemia. Eur. J. Clin. Pharmacol. 42: 61-64 (1992)
21. Rossato, M., G. Guarneri, T. Lavagnini, D. Padovan, C. Foresta: Simvastatin influences testicular steroidogenesis in humans. Horm. Metab. Res. 25: 503-505 (1993)
22. Saez, J. M., M. G. Forest: Kinetics of human Chorionic Gonadotropin-induced steroidogenic response of the human testis. I. Plasma testosterone: implications for Human Chorionic Gonadotropin-stimulation test. J. Clin. Endocrinol. Metab. 49: 278-283 (1979)
23. Sairam, M., G. Bhargavi: A role for glycosylation of the alpha subunit in transduction of biological signal in glycoprotein hormones. Science 229: 65-68 (1985)
24. Smals, A. G. H., J. A. M. Weusten, T. J. Benraad, P. W. C. Kloppenborg: The HMG-CoA reductase inhibitor simvastatin suppresses human testicular testosterone synthesis in vitro by a selective inhibitory effect on 17-ketosteroid-oxidoreductase enzyme activity. J. Steroid. Biochem. Mol. Biol. 38: 465-468 (1991)
25. Tobert, J. A., G. D. Bell, J. Birtwell, I. James, W. R. Kukovetz, J. S. Pryor, A. Buntinx, I. B. Holmes, Y. S. Chao, J. A. Bolognese: Cholesterol lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, in healthy volunteers. J. Clin. Invedst. 69: 913-919 (1982)
26. Vanderpump, M. P. J., W. M. G. Tunbridge: The effects of drugs on endocrine function. Clin. Endocrinol. 39: 389-397 (1993)
27. Vermeulen, A.: Androgens in the aging male. J. Clin. Endocrinol. Metab. 73: 221-224 (1991)